Get the Stockscreener App
1.285
1.98%
0.025
After Hours:
1.29
0.005
+0.39%
Mira Pharmaceuticals Inc stock is traded at $1.285, with a volume of 195.30K.
It is up +1.98% in the last 24 hours and down -11.38% over the past month.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
See More
Previous Close:
$1.26
Open:
$1.27
24h Volume:
195.30K
Relative Volume:
0.24
Market Cap:
$24.50M
Revenue:
-
Net Income/Loss:
$-11.24M
P/E Ratio:
-1.6875
EPS:
-0.7615
Net Cash Flow:
$-4.79M
1W Performance:
-4.81%
1M Performance:
-11.38%
6M Performance:
+48.57%
1Y Performance:
+17.89%
1-Day Range:
$1.26
$1.2999
1-Week Range:
$1.25
$1.37
52-Week Range:
$0.73
$2.56
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals Inc
Sector
Industry
Phone
813-369-5150
Address
1200 BRICKELL AVENUE, MIAMI
Compare MIRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.285 | 24.03M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
819.40 | 747.19B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
190.90 | 459.32B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
230.30 | 407.19B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
129.12 | 251.72B | 53.40B | 13.68B | 16.89B | 6.8864 |
|
MRK
Merck Co Inc
|
85.70 | 214.78B | 63.43B | 16.42B | 14.72B | 6.4861 |
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
Trend analysis for MIRA Pharmaceuticals Inc. this week2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Is MIRA Pharmaceuticals Inc. stock a contrarian buy2025 EndofYear Setup & Safe Capital Investment Plans - newser.com
Price momentum metrics for MIRA Pharmaceuticals Inc. explainedWeekly Trade Recap & Community Verified Trade Signals - newser.com
How to manage a losing position in MIRA Pharmaceuticals Inc.Portfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com
Should you wait for a breakout in MIRA Pharmaceuticals Inc.2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - newser.com
Can MIRA Pharmaceuticals Inc. stock surprise with earnings upsideFed Meeting & High Accuracy Swing Entry Alerts - newser.com
MIRA Pharmaceuticals reports positive in vitro drug release data for topical Ketamir-2 - MSN
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - Livingston Daily
What drives MIRA Pharmaceuticals Inc stock priceStock Price Targets & Budget Investment Success - earlytimes.in
Is MIRA Pharmaceuticals Inc. stock a buy in volatile marketsMarket Sentiment Report & Technical Pattern Alert System - newser.com
MIRA Pharmaceuticals Inc. stock daily chart insightsPortfolio Profit Report & Precise Swing Trade Alerts - newser.com
What machine learning models say about MIRA Pharmaceuticals Inc.Weekly Risk Summary & Proven Capital Preservation Tips - newser.com
MIRA Pharmaceuticals Inc Stock Analysis and ForecastTechnical Resistance Breaks & Free Hedging Tactics for Volatile Markets - earlytimes.in
Published on: 2025-10-09 04:14:21 - newser.com
Is MIRA Pharmaceuticals Inc. reversing from oversold territory2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
What analysts say about MIRA Pharmaceuticals Inc stockEquity Performance Review & Low Cost Trading Plans - earlytimes.in
What indicators show strength in MIRA Pharmaceuticals Inc.Market Performance Recap & AI Optimized Trading Strategy Guides - newser.com
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - Fall River Herald News
Is MIRA Pharmaceuticals Inc. a candidate for recovery playPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals - El Paso Times
What data driven models say about MIRA Pharmaceuticals Inc.’s futureWeekly Profit Analysis & Consistent Growth Equity Picks - newser.com
Can MIRA Pharmaceuticals Inc. stock sustain free cash flow growth2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Using fundamentals and technicals on MIRA Pharmaceuticals Inc.Market Activity Report & Fast Moving Stock Watchlists - newser.com
Analyzing MIRA Pharmaceuticals Inc. with multi timeframe chartsJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Rating Upgraded by Wall Street Zen - Defense World
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction - The Oklahoman
Custom strategy builders for tracking MIRA Pharmaceuticals Inc.July 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
MIRA Pharmaceuticals Completes SKNY Acquisition - MSN
What moving averages say about MIRA Pharmaceuticals Inc.New Guidance & Free Safe Entry Trade Signal Reports - newser.com
MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals By Investing.com - Investing.com Nigeria
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals - citybiz
Mira Pharmaceuticals completes acquisition of SKNY Pharmaceuticals By Investing.com - Investing.com Nigeria
MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals - Investing.com
Mira Pharmaceuticals Inc Stock (MIRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):